DUBLIN, April 27, 2023 - The "qPCR and dPCR Instrumentation: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global qPCR and dPCR Instrumentation Market to Reach $13.5 Billion by 2030

The global market for qPCR and dPCR Instrumentation estimated at US$7.1 Billion in the year 2022, is projected to reach a revised size of US$13.5 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2022-2030.

qPCR, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$11.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the dPCR segment is readjusted to a revised 11.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 11.2% CAGR

The qPCR and dPCR Instrumentation market in the U.S. is estimated at US$2.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Looking Ahead to 2023

Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year.

Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers.

Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New for 2023?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year
Key Topics Covered:

MARKET OVERVIEW

Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
Impact of Covid-19 and a Looming Global Recession
Impact of COVID-19 on Clinical Diagnostics
Emergence of PCR as a Preferred COVID-19 Detection Method
Performance Analysis of COVID-19 Tests
Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market
Select Approved Covid-19 Molecular Assay Tests
Recent PCR Based Tests
Digital PCR Sparks Increasing Interest
High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19
CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Real-Time PCR and Digital PCR: Scope and Definition
Real-Time PCR or Quantitative PCR (qPCR)
qPCR Instrumentation
Disadvantages
Advantages of qPCR
End-Use Applications of qPCR
Digital PCR (dPCR)
Working Principle
Applications of dPCR
Advantages of dPCR
qPCR Remains the Mainstay Technology
Digital PCR to Experience Strong Growth
High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
Developing Countries Drive Growth Opportunities
Competition
Competitive Factors
Accelerated Commercialization of Products
Manufacturers Step-Up Online Exposure
Targeted Expansion of Distribution Reach and Global Footprint
Recent Market Activity
MARKET TRENDS & DRIVERS

Striking the Right Balance between qPCR and dPCR in Research Laboratories
qPCR: A Suitable Tool for Gene Expression and Validation
Digital PCR Takes Quantification of Nucleic Acids to the Next Level
dPCR: A Valuable Tool in Virology Research
Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
dPCR for Analyzing Hematologic Malignancies
dPCR for Liquid Biopsies
Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
Rise in Infectious Diseases Drives Opportunities for Biochips
Innovations in Instrumentation Expand Functionality and Drive Adoption
Advancements in Probe Technology Enhance qPCR Sensitivity
qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment
Lab on Chip/Microfluidic Real-time-PCR
Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
ddPCR: The More Advanced Digital Approach to dPCR
ddPCR Gains Traction in Cancer Diagnosis
Monitoring Disease Progression in HIV Studies
Analysis of Genetically Modified Organisms in Edible Products
RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
Technology Advancements Aid in Overcoming Barriers
Alternate Technologies Pose Threat to Growth of PCR Market
Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19
Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
PCR in Forensic and Paternity Testing
FOCUS ON SELECT PLAYERS (Total 74 Featured)

Agilent Technologies, Inc.
Becton, Dickinson and Company
BioFire Diagnostics, Inc.
Bio-Rad Laboratories, Inc.
Cepheid
Eppendorf AG
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
Promega Corporation
QIAGEN N.V.
Takara Bio, Inc.
Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/3v71yi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716